Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if YCBD is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
4 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
27 filers reported a long position in YCBD for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Worth Venture Partners, LLC | $124.4K | 184.8K | Unchanged |
| CSS LLC/IL | $92.6K | 137.6K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $80.5K | 119.6K | +134.4% |
| CHAPIN DAVIS, INC. | $54.7K | 81.3K | Unchanged |
| Alesco Advisors, LLC, An ESL Co | $46.1K | 68.5K | Unchanged |
| Chicago Partners Investment Group LLC | $45K | 78.1K | +478.5% |
| XTX Topco Ltd | $42.2K | 62.7K | -31.8% |
| JANE STREET GROUP, LLC | $36.6K | 54.4K | -28.7% |
| VANGUARD FIDUCIARY TRUST CO | $31.7K | 47.2K | Unchanged |
| UBS Group AG | $14.5K | 21.6K | -86.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.